Global Vaccine Access

Debate between Theo Clarke and Philippa Whitford

Thursday 13th January 2022 Westminster Hall

[Theo Clarke (Stafford) (Con)]

It is a pleasure to serve under your chairmanship, Mrs Murray. I congratulate the hon. Member for North East Fife (Wendy Chamberlain) on securing this important debate on global vaccine access.

I start by thanking the healthcare workers, NHS staff and volunteers who have helped Britain to have one of the most successful coronavirus vaccination programmes in the world. I also pay tribute to our scientists who have worked to develop coronavirus vaccines, and thank the Government for funding this vaccine development. I was grateful to receive my vaccines at the Kingston Centre and St George’s Hospital in Stafford, and I was delighted to hear that over 2.5 million vaccines were given in the west midlands in December alone. Seeing the vaccine roll-out in my own Stafford constituency has made me passionate about the need for global vaccine access.

Britain has always been at the forefront of global healthcare. The efforts of consecutive British Governments and the generosity of the British public has helped to eliminate many diseases globally. Britain was a founding member of GAVI, the Vaccine Alliance, and this Government are continuing to champion access to vaccines.

As Chair of the International Development Sub-Committee, I welcomed the Independent Commission for Aid Impact’s recent information note on GAVI that highlighted the need to establish worldwide vaccination programmes for dangerous diseases, such as polio, as well as rolling out coronavirus vaccinations. In September, I met with GAVI at its headquarters in Geneva, to discuss the coronavirus vaccine roll-out, and to ensure that the poorest and most marginalised communities in the world are not left behind.

I welcome that Britain is one of the most generous donors to GAVI, pledging £1.65 billion from 2020 to 2025. During the height of the pandemic in June 2020, Britain led the hosting of the GAVI replenishment conference, and I was pleased that fundraising target the was exceeded, with world leaders pledging $8.8 billion. That was a crucial step in tackling the coronavirus pandemic, which, as we know from experience, shows that vaccines do work in protecting us from infectious illnesses.

Polio provides another example of how vaccines can be used to tackle terrible diseases. In 1988, over 70 million people worldwide were infected with polio, and more than 350,000 people developed paralytic polio. The Government’s generous financial support for the Global Polio Eradication Initiative meant that 2018 saw only 33 cases of polio worldwide. That represents millions of people being saved from the perils of polio by one simple vaccine. That is a real example of how vaccination programmes do work, and why we must follow this model and continue to provide global access to vaccines in order to end the coronavirus pandemic.

[Dr Philippa Whitford (Central Ayrshire) (SNP)]

Will the hon. Member give way?

[Theo Clarke]

I will not take interventions at the moment. As vice-chair of the all-party parliamentary group for Africa, and having visited numerous health programmes across eastern, southern and western Africa, I have seen at first hand the devasting impact that diseases can have on people already living in challenging circumstances. I welcome the recent breakthrough with the malaria vaccine which, like the coronavirus vaccine, has the potential to make a real difference throughout the developing world.

I repeatedly raised the importance of COVAX with the then Foreign Secretary, my right hon. Friend the Member for Esher and Walton (Dominic Raab), and have done so again with other Foreign Office Ministers, including raising the issue in the Chamber and in International Development Committee evidence sessions. I welcome that Britain took the lead regarding COVAX when hosting the G7 last summer, committing the UK to providing 80 million vaccine doses and helping to secure commitments to COVAX of nearly $10 billion from other developed countries. The Government should be commended for meeting their ambitious target to donate 30 million vaccines to COVAX by the end of 2021.

On my visits to Kenya, as trade envoy, I have seen at first hand the difference these COVAX vaccines have made. On my most recent visit in November, I went to the Kenyatta University Hospital and met with Kenyan doctors and healthcare professionals. This hospital in Nairobi works in partnership with the University of Manchester in order to improve healthcare treatments and tackle infectious diseases. The British also developed the Oxford AstraZeneca vaccine, which has helped to save lives and improve the life chances of people living in Kenya; I am pleased this has been replicated across the Commonwealth, with over 2.5 billion doses being used in over 170 countries. At the G7 the Prime Minister said that we need a plan to vaccinate the world. If we want a definitive end to this pandemic, then I agree with him.